Article info

Download PDFPDF
CASE REPORT
The novel use of botulinum toxin A for the treatment of Raynaud’s phenomenon in the toes

Authors

  • Kiran Dhaliwal UCL Centre for Nanotechnology and Regenerative Medicine, Royal Free Hospital, London, UKCharles Wolfson Center for Reconstructive Surgery, Royal Free Hospital, London, UK PubMed articlesGoogle scholar articles
  • Michelle Griffin UCL Centre for Nanotechnology and Regenerative Medicine, Royal Free Hospital, London, UKCharles Wolfson Center for Reconstructive Surgery, Royal Free Hospital, London, UK PubMed articlesGoogle scholar articles
  • Christopher P Denton Experimental Rheumatology Department, Centre for Rheumatology and Connective Tissue Diseases, Royal Free Hospital, London, UKDivision of Medicine, University College London, London, UK PubMed articlesGoogle scholar articles
  • Peter E M Butler UCL Centre for Nanotechnology and Regenerative Medicine, Royal Free Hospital, London, UKCharles Wolfson Center for Reconstructive Surgery, Royal Free Hospital, London, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Kiran Dhaliwal, kirandhaliwal50{at}gmail.com
View Full Text

Citation

Dhaliwal K, Griffin M, Denton CP, et al
The novel use of botulinum toxin A for the treatment of Raynaud’s phenomenon in the toes

Publication history

  • Accepted February 25, 2018
  • First published March 9, 2018.
Online issue publication 
August 07, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.